Eastwood Bio-Medical Canada Inc
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and… Read more
Market Cap & Net Worth: Eastwood Bio-Medical Canada Inc (EWOOF)
Eastwood Bio-Medical Canada Inc (PINK:EWOOF) has a market capitalization of $47.79 Million ($47.79 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #26890 globally and #9057 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Eastwood Bio-Medical Canada Inc's stock price $0.69 by its total outstanding shares 68886000 (68.89 Million).
Eastwood Bio-Medical Canada Inc Market Cap History: 2018 to 2024
Eastwood Bio-Medical Canada Inc's market capitalization history from 2018 to 2024. Data shows growth from $277.96 Million to $47.79 Million (0.91% CAGR).
Eastwood Bio-Medical Canada Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Eastwood Bio-Medical Canada Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
76.41x
Eastwood Bio-Medical Canada Inc's market cap is 76.41 times its annual revenue
0.36x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $277.96 Million | $743.97K | -$861.98K | 373.62x | N/A |
| 2019 | $112.96 Million | $983.67K | -$439.25K | 114.83x | N/A |
| 2020 | $78.18 Million | $538.75K | -$639.32K | 145.11x | N/A |
| 2021 | $82.66 Million | $791.81K | -$487.16K | 104.40x | N/A |
| 2022 | $82.66 Million | $953.77K | -$109.98K | 86.67x | N/A |
| 2023 | $47.79 Million | $625.37K | -$546.60K | 76.41x | N/A |
Competitor Companies of EWOOF by Market Capitalization
Companies near Eastwood Bio-Medical Canada Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Eastwood Bio-Medical Canada Inc by market ranking:
- Sysco Corporation (NYSE:SYY): Ranked #529 globally with a market cap of $40.36 Billion USD.
- US Foods Holding Corp (NYSE:USFD): Ranked #970 globally with a market cap of $20.11 Billion USD.
- Performance Food Group Co (NYSE:PFGC): Ranked #1348 globally with a market cap of $13.32 Billion USD.
- Bunzl plc (PINK:BZLFF): Ranked #1824 globally with a market cap of $8.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #529 | Sysco Corporation | NYSE:SYY | $40.36 Billion | $84.52 |
| #970 | US Foods Holding Corp | NYSE:USFD | $20.11 Billion | $91.74 |
| #1348 | Performance Food Group Co | NYSE:PFGC | $13.32 Billion | $86.63 |
| #1824 | Bunzl plc | PINK:BZLFF | $8.90 Billion | $41.45 |
Eastwood Bio-Medical Canada Inc Historical Marketcap From 2018 to 2024
Between 2018 and today, Eastwood Bio-Medical Canada Inc's market cap moved from $277.96 Million to $ 47.79 Million, with a yearly change of 0.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $47.79 Million | 0.00% |
| 2023 | $47.79 Million | -42.19% |
| 2022 | $82.66 Million | 0.00% |
| 2021 | $82.66 Million | +5.74% |
| 2020 | $78.18 Million | -30.79% |
| 2019 | $112.96 Million | -59.36% |
| 2018 | $277.96 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2025 the market cap of Eastwood Bio-Medical Canada Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $47.79 Million USD |
| MoneyControl | $47.79 Million USD |
| MarketWatch | $47.79 Million USD |
| marketcap.company | $47.79 Million USD |
| Reuters | $47.79 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.